Gilead Sciences

YTD

ALL

Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About GILD

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.

CEO

Daniel P. O'Day

CEODaniel P. O'Day

Employees

17,600

Employees17,600

Headquarters

Foster City, California

HeadquartersFoster City, California

Founded

1987

Founded1987

Employees

17,600

Employees17,600

GILD Key Statistics

Market cap

133.70B

Market cap133.70B

Price-Earnings ratio

293.83

Price-Earnings ratio293.83

Dividend yield

2.76%

Dividend yield2.76%

Average volume

9.77M

Average volume9.77M

High today

$113.46

High today$113.46

Low today

$106.02

Low today$106.02

Open price

$110.53

Open price$110.53

Volume

12.92M

Volume12.92M

52 Week high

$119.96

52 Week high$119.96

52 Week low

$62.07

52 Week low$62.07

GILD News

Benzinga 2d

Amazon, Alphabet, KLA And A Health Care Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Rob Sechan of NewEdge Wealth said Gilead Sciences, Inc. GILD is one of the best-performing names in one of the best-pe...

Analyst ratings

61%

of 31 ratings

Buy

61.3%

Hold

35.5%

Sell

3.2%